|
48
|
273
|
4rhv1 |
The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure |
|
28
|
204
|
4qpgB |
Crystal structure of empty hepatitis a virus |
|
2
|
40
|
4rhv4 |
The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure |
|
141
|
461
|
4r0eA |
Crystal structure of the poliovirus rna-dependent rna polymerase low-fidelity mutant 3dpol h273r |
|
49
|
274
|
4pdwA |
A benzonitrile analogue inhibits rhinovirus replication |
|
198
|
562
|
4oowA |
Hcv ns5b polymerase with a fragment of quercetagetin |
|
41
|
159
|
4qbbA |
Structure of the foot-and-mouth disease virus leader proteinase in complex with inhibitor (n~2~-[(3s)-4-({(2r)-1-[(4-carbamimidamidobutyl)amino]-4-methyl-1-oxopentan-2-yl}amino)-3-hydroxy-4-oxobutanoyl]-l-arginyl-l-prolinamide) |
|
56
|
255
|
4pdwB |
A benzonitrile analogue inhibits rhinovirus replication |
|
1
|
9
|
4q0xE |
Crystal structure of non-neutralizing antibody in complex with epitope ii of hcv e2 |
|
41
|
231
|
4pdwC |
A benzonitrile analogue inhibits rhinovirus replication |
|
146
|
461
|
4nlwA |
Poliovirus polymerase - g289a/c290i loop mutant |
|
140
|
461
|
4nlqA |
Poliovirus polymerase - c290f loop mutant |
|
44
|
177
|
4oiiA |
West nile virus ns1 in complex with neutralizing 22ns1 antibody fab |
|
138
|
461
|
4nlxA |
Poliovirus polymerase - g289a/c290v loop mutant |
|
206
|
562
|
4mk8A |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 4 (n-(4-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]ethyl}phenyl)methanesulfonamide) |
|
206
|
568
|
4mz4A |
Discovery of an irreversible hcv ns5b polymerase inhibitor |
|
35
|
175
|
4oigA |
Dengue virus non-structural protein ns1 |
|
140
|
461
|
4nlsA |
Poliovirus polymerase - s288a loop mutant |
|
143
|
461
|
4nloA |
Poliovirus polymerase - c290i loop mutant |
|
139
|
461
|
4nlpA |
Poliovirus polymerase - c290v loop mutant |
|
142
|
461
|
4nluA |
Poliovirus polymerase - g289a loop mutant |
|
203
|
614
|
4mtpA |
Rdrp from japanesese encephalitis virus |
|
77
|
353
|
4o6cA |
West nile virus non-structural protein 1 (ns1) form 2 crystal |
|
142
|
461
|
4nlrA |
Poliovirus polymerase - c290s loop mutant |
|
71
|
350
|
4o6bA |
Dengue type2 virus non-structural protein 1 (ns1) form 1 crystal |
|
135
|
461
|
4nltA |
Poliovirus polymerase - s291p loop mutant |
|
44
|
177
|
4oieA |
West nile virus non-structural protein ns1 |
|
88
|
377
|
4o6dB |
West nile virus non-structural protein 1 (ns1) form 1 crystal |
|
142
|
461
|
4nlvA |
Poliovirus polymerase - g289a/c290f loop mutant |
|
140
|
461
|
4nlyA |
Poliovirus polymerase - c290e loop mutant |
|
166
|
505
|
4nldA |
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase complex with bms-791325 also known as (1ar,12bs)-8-cyclohexyl-n-(dimethylsulfamoyl)-11-methoxy-1a-{[(1r,5s)-3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl]carbonyl}-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide and 2-(4-fluorophenyl)-n-methyl-6-[(me |
|
200
|
554
|
4obcA |
Crystal structure of hcv polymerase ns5b genotype 2a jfh-1 isolate with the s15g, c223h, v321i resistance mutations against the guanosine analog gs-0938 (psi-3529238) |
|
93
|
359
|
4o6dA |
West nile virus non-structural protein 1 (ns1) form 1 crystal |
|
3
|
11
|
4n0yA |
Structure of the hepatitis c envelope glycoprotein e1 antigenic region 314-324 bound to the cross-neutralizing antibody igh526 |
|
28
|
203
|
4mwfC |
Structure of hepatitis c virus envelope glycoprotein e2 core bound to broadly neutralizing antibody ar3c |
|
201
|
562
|
4mk9A |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 12 (n-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide) |
|
39
|
142
|
4mg3A |
Crystal structural analysis of 2a protease from coxsackievirus a16 |
|
44
|
233
|
4m9mA |
Ns2b-ns3 protease from dengue virus at ph 8.5 |
|
204
|
562
|
4mkaA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 13 (n-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide) |
|
47
|
233
|
4m9kA |
Ns2b-ns3 protease from dengue virus at ph 5.5 |
|
203
|
562
|
4mk7A |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 2 (3-(3-tert-butyl-4-methoxyphenyl)pyridin-2(1h)-one) |
|
46
|
233
|
4m9iA |
A125c ns2b-ns3 protease from dengue virus at ph 5.5 |
|
334
|
891
|
4k6mA |
Crystal structure of the full-length japanese encephalitis virus ns5 |
|
206
|
562
|
4mkbA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 14 (n-(4-{(e)-2-[3-tert-butyl-2-methoxy-5-(3-oxo-2,3-dihydropyridazin-4-yl)phenyl]ethenyl}phenyl)methanesulfonamide) |
|
195
|
562
|
4miaA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with rg7109 (n-{4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-2,5-dihydropyridin-3-yl)quinolin-3-yl]phenyl}methanesulfonamide) |
|
44
|
233
|
4m9fA |
Dengue virus ns2b-ns3 protease a125c variant at ph 8.5 |
|
202
|
562
|
4mibA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with compound 48 (n-({(3s)-1-[6-tert-butyl-5-methoxy-8-(2-oxo-1,2-dihydropyridin-3-yl)quinolin-3-yl]pyrrolidin-3-yl}methyl)methanesulfonamide) |
|
54
|
226
|
4m9tA |
Ns2b-ns3 protease from dengue virus in the presence of dtnb, a covalent allosteric inhibitor |
|
200
|
563
|
4ju1A |
Crystal structure of hcv ns5b polymerase in complex with compound 6 |
|
197
|
563
|
4jy1A |
Crystal structure of hcv ns5b polymerase in complex with compound 5 |
